Skip to main content
OpenTrials

Clinical trial condition

Noninsulin-dependent diabetes mellitus with deafness

Explore clinical trials studying Noninsulin-dependent diabetes mellitus with deafness. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Noninsulin-dependent diabetes mellitus with deafness trial results

Recruiting

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

NCT06451757

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +22 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Cleveland Clinic Neurological Institute Mellen Center Cleveland, Ohio, United States
  • The University of Texas Health Science Center at Houston Houston, Texas, United States
  • Rigshospitalet, University of Copenhagen Kopenhagen, Region Sjælland, Denmark
View Trial Details
Completed

OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)

NCT05972954

Conditions
Acid-Base Imbalance, Acidosis, Acidosis, Lactic, +44 more
Locations
  • Universitätsklinikum Bonn, Sektion Neuromuskuläre Erkrankungen, Klinik und Poliklinik für Neurologie, Venusberg-Campus 1, Gebäude 80, NPP Bonn, Germany
  • Medizinisch Fakultät der Martin-Luther-Universität Halle-Wittenberg Universitätsklinik und Poliklinik für Neurologie Universitätsklinikum , Ernst-Grube-Str. 40 Halle, Germany
  • Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU Klinikum), Ziemssenstr. 1a Munich, Germany
  • IRCCS Institute of Neurological Science of Bologna, University of Bologna, Department of Biomedical and Neuromotor Science (DIBINEM), Ospedale Bellaria Via Altura, 3 Bologna, Italy
View Trial Details
Completed

The KHENEREXT Study

NCT04604548

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +35 more
Locations
  • Rigshospitalet, University of Copenhagen Copenhagen, Denmark
  • Klinikum der Universität München Friedrich-Baur-Institut München, Germany
  • Radboud University Medical Center Nijmegen, Netherlands
  • Institute for Ageing and Health Newcastle University Newcastle upon Tyne, United Kingdom
View Trial Details
Completed

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

NCT01383759

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions